Swiss Re’s Idexx Laboratories IDXX Stock Holding History

Swiss Re’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.2K	Hold	20	–	–	0.07%	202
2025 Q4	$13.5K	Buy	+20	New	+$13.6K	﹤0.01%	187

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swiss Re's IDXX Position: Q1 2026 in Review

Swiss Re held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 20 shares worth $11.2K. The position accounts for 0.07% of the portfolio, ranked #202.

Swiss Re first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. The position peaked at $13.5K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Swiss Re held 20 shares of Idexx Laboratories worth $11.2K as of Q1 2026.
Swiss Re left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.07% of Swiss Re's portfolio in Q1 2026, its #202 holding.
Swiss Re first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
Swiss Re's Idexx Laboratories position peaked at $13.5K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Swiss Re's 13F filing for Q1 2026, filed 12 May 2026.